Royalty Pharma PLC (RPRX) Social Stream
ROYALTY PHARMA PLC (RPRX) Price Targets From Analysts
Use the tables below to see what analysts covering ROYALTY PHARMA PLC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 8 | $56.001 | $46 | $51.714 | $28.33 | 82.54% |
| 2022-02-02 | 7 | $56 | $46 | $51.714 | $28.33 | 82.54% |
| 2022-03-08 | 7 | $56 | $46 | $51.142 | $28.33 | 80.52% |
| 2022-04-06 | 7 | $56 | $48 | $51.428 | $28.33 | 81.53% |
| 2022-05-06 | 7 | $56 | $48 | $51.428 | $28.33 | 81.53% |
| 2022-06-09 | 9 | $56 | $48 | $52.111 | $28.33 | 83.94% |
| 2022-06-14 | 10 | $56 | $47 | $51.6 | $28.33 | 82.14% |
| 2022-08-03 | 10 | $57 | $47 | $52.3 | $28.33 | 84.61% |
| 2022-10-12 | 10 | $57 | $47 | $52.6 | $28.33 | 85.67% |
| 2022-10-27 | 10 | $57 | $47 | $52.8 | $28.33 | 86.37% |
| 2022-11-28 | 9 | $57 | $47 | $53.111 | $28.33 | 87.47% |
| 2022-12-06 | 9 | $57 | $47 | $52.777 | $28.33 | 86.29% |
| 2023-02-15 | 9 | $57 | $47 | $52 | $28.33 | 83.55% |
| 2023-03-29 | 9 | $57 | $47 | $52.111 | $28.33 | 83.94% |
| 2023-04-10 | 9 | $57 | $47 | $52.333 | $28.33 | 84.73% |
| 2023-04-21 | 9 | $60 | $42 | $50.625 | $28.33 | 78.7% |
| 2023-05-10 | 8 | $60 | $42 | $50.875 | $28.33 | 79.58% |
| 2023-06-06 | 7 | $60 | $42 | $49.857 | $28.33 | 75.99% |
| 2023-07-11 | 4 | $60 | $42 | $49.333 | $28.33 | 74.14% |
| 2023-08-08 | 5 | $60 | $42 | $49.333 | $28.33 | 74.14% |
| 2023-08-09 | 5 | $60 | $42 | $49.833 | $28.33 | 75.9% |
| 2023-11-08 | 5 | $60 | $40 | $48.833 | $28.33 | 72.37% |
| 2023-11-10 | 5 | $60 | $40 | $48.666 | $28.33 | 71.78% |
| 2023-12-12 | 7 | $60 | $37 | $46.285 | $28.33 | 63.38% |
The Trend in the Analyst Price Target
Over the past 30 months, RPRX's average price target has gone down $6.43.
RPRX reports an average of 55.15% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-14 | 9 | 57 | 47 | 52.333 | 38.00 | 37.72% |
| 2023-07-11 | 5 | 60 | 42 | 49.333 | 30.71 | 60.64% |
| 2023-10-02 | 5 | 60 | 40 | 48.666 | 26.81 | 81.52% |
| 2023-11-10 | 5 | 60 | 40 | 49.428 | 27.22 | 81.59% |
| 2023-12-12 | 6 | 60 | 37 | 46.285 | 28.51 | 62.35% |
RPRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.21 | 5 | 2 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
RPRX's average broker recommendation rating worsened by 0.11 over the prior 35 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RPRX as an investment opportunity.
- In terms of how ROYALTY PHARMA PLC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 2360.14% of that group.
- In the context of stocks in the large market cap category, ROYALTY PHARMA PLC's number of analysts covering the stock is greater than 437.57% of them.
- In terms of how ROYALTY PHARMA PLC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -395.84% of that group.
- In the context of Pharmaceutical Products stocks, ROYALTY PHARMA PLC's average analyst price target is greater than 2146.66% of them.
Stocks similar to ROYALTY PHARMA PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RGNX, HALO, and BCRX.
View All Top Stocks by Price Target
Is RPRX a Buy, Hold or Sell? See the POWR Ratings now!